Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pricing Strategies; Reimbursement

Set Alert for Pricing Strategies and Reimbursement

Pricing Strategies

Teva Stays Silent On Settlement Suspension Stories

Amid media reports of Teva walking away from settlement negotiations with the US Department of Justice over generic price-fixing allegations, the Israeli company is officially maintaining silence over the matter.

Legal Issues Pricing Strategies

Erythromycin And Paracetamol See April Rises In UK

Erythromycin and paracetamol were among the products with the steepest price rises in the UK in April, as the coronavirus pandemic continued to make its effects felt in the generics market.

Market Intelligence United Kingdom

Gedeon Richter Chief Makes Biosimilars Prophecy

Gedeon Richter has high ambitions for biosimilars, recently penning a deal to bring in a tocilizumab biosimilar that is currently under development. During its first-quarter earnings call, the Hungarian company’s CEO gave his current thinking on how payers may treat biosimilars amidst the COVID-19 pandemic.

Biosimilars Coronavirus COVID-19

Apotex Pays Out Over US Price-Fixing Claims

Apotex has agreed to pay a $24.1m fine and enter into a deferred prosecution agreement to resolve US price-fixing claims over the cholesterol-lowering drug pravastatin.

Legal Issues United States

Belgian Body Welcomes Clawback Exemption Amid Price Cuts

Belgian body Medaxes is content with the latest pharmaceutical pricing legislation in the country, which cuts generics and biosimilars prices but also exempts such drugs from pharmaceutical clawback taxes.

Pricing Strategies Policy

UK Supply Chain Disruption Due To Closed Borders Remains A Concern

The BGMA has emphasized the importance of prioritizing transport of medicines across borders, at the same time as it has praised decisions by the UK competition authority and European Commission to relax rules on co-ordinating to facilitate the supply of medicines.

United Kingdom Coronavirus COVID-19
See All
UsernamePublicRestriction

Register